Tempus AI Hits Major Profit Goal Amidst Rapid Q3 2025 Growth
Tempus AI achieved its 10-year profitability target in Q3 2025, driven by massive 84.7% revenue growth and exceptional performance in its genomics and clinical testing divisions.
Tempus AI achieved its 10-year profitability target in Q3 2025, driven by massive 84.7% revenue growth and exceptional performance in its genomics and clinical testing divisions.
Ross Stores surprises with strong fourth-quarter profits and sales growth, driven by rising same-store sales. The off-price retailer eyes continued momentum in 2026 amid economic challenges.
GitLab beats Q4 estimates with $260.4M in revenue (+23% YoY) and $0.30 non-GAAP EPS. The company also announced a $400M share repurchase program. FY2027 guidance calls for $1.10–$1.12B in revenue, coming in below consensus.
Moderna agrees to $2.25B settlement with Arbutus Biopharma and Genevant, paying $950M upfront + up to $1.3B contingent. Ends all COVID vaccine patent litigation worldwide.